Pasithea Therapeutics Equity Warrant Exp 11th Aug 2026 KTTAW:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/08/22 EDT
0.0721UNCH (UNCH)
Volume
1
52 week range
0.06 - 1.59
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0721
  • 52 Week High1.59
  • 52 Week High Date11/23/21
  • 52 Week Low0.06
  • 52 Week Low Date06/23/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0721
  • 52 Week High1.59
  • 52 Week High Date11/23/21
  • 52 Week Low0.06
  • 52 Week Low Date06/23/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pasithea Therapeutics Equity Warrant Exp 11th Aug 2026

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Pasithea Therapeutics Corp. is a biotechnology company. The Company is engaged on psychiatric and neurological research regarding central nervous system (CNS) disorders with focus on translating the research into clinic-ready drugs. The Company's secondary operations are focused on establishing anti-depression clinics across the United Kingdom and providing business support services to similar entities in the United States and using psychiatric assessment combined with...
Address
2110 Narcissus Ct
Venice, CA
90291
United States